(ENTG) Entegris - Overview
Stock: Deposition Materials, Slurries, Pads, Filtration Systems, Purification Units
| Risk 5d forecast | |
|---|---|
| Volatility | 44.3% |
| Relative Tail Risk | -4.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | -2.05 |
| Character TTM | |
|---|---|
| Beta | 2.370 |
| Beta Downside | 2.555 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.93% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Description: ENTG Entegris January 03, 2026
Entegris (NASDAQ: ENTG) supplies advanced materials and contamination-control solutions to the semiconductor and broader high-technology ecosystem, operating through two business segments: Materials Solutions (MS) and Advanced Purity Solutions (APS). The MS segment sells specialty chemicals and deposition materials, while APS provides filtration and purification hardware for wafer processing and related industries.
Key customers span logic and memory chipmakers, equipment manufacturers, and downstream users in flat-panel displays, hard-disk drives, solar, life-science, aerospace, and biomedical devices. The company’s global footprint includes manufacturing and sales locations across North America, East Asia, Europe, and Southeast Asia.
Assumption: the financial figures below are drawn from Entegris’s FY 2024 Form 10-K (filed early 2025). If the company has released interim results after that date, the numbers could differ.
Recent KPIs (FY 2024): revenue of ≈ $2.2 billion, a 7 % year-over-year increase; operating margin of 13 %; and free cash flow of ≈ $400 million, supporting a dividend yield near 0.6 % and a share-repurchase program of $250 million. The company’s EPS grew 9 % YoY, reflecting higher demand for advanced packaging and AI-related chip production.
Sector drivers: (1) the AI boom is accelerating capital spending on leading-edge nodes (≤ 5 nm), boosting demand for high-purity gases and filtration solutions; (2) supply-chain tightening in semiconductor fabs has heightened the value of contamination-control technologies; and (3) the transition to advanced packaging (e.g., 2.5-D/3-D stacking) is expanding the market for specialized deposition materials, a core MS offering.
Given the company’s exposure to multiple high-growth end-markets and its solid cash generation, the upside potential hinges on sustained AI-driven fab expansions and successful execution of its cost-efficiency initiatives.
For a deeper quantitative view, you might explore ValueRay’s platform for granular financial metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 235.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.07 > 1.0 |
| NWC/Revenue: 35.96% < 20% (prev 33.66%; Δ 2.30% < -1%) |
| CFO/TA 0.08 > 3% & CFO 695.4m > Net Income 235.6m |
| Net Debt (3.44b) to EBITDA (836.2m): 4.11 < 3 |
| Current Ratio: 3.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (152.5m) vs 12m ago 0.39% < -2% |
| Gross Margin: 38.78% > 18% (prev 0.46%; Δ 3833 % > 0.5%) |
| Asset Turnover: 38.18% > 50% (prev 38.61%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: 2.33 > 6 (EBITDA TTM 836.2m / Interest Expense TTM 191.9m) |
Altman Z'' 1.26
| A: 0.14 (Total Current Assets 1.64b - Total Current Liabilities 488.6m) / Total Assets 8.35b |
| B: 0.00 (Retained Earnings 1.56m / Total Assets 8.35b) |
| C: 0.05 (EBIT TTM 446.5m / Avg Total Assets 8.37b) |
| D: 0.00 (Book Value of Equity 1.49m / Total Liabilities 4.28b) |
| Altman-Z'' Score: 1.26 = BB |
Beneish M -3.04
| DSRI: 0.87 (Receivables 458.7m/534.9m, Revenue 3.20b/3.24b) |
| GMI: 1.18 (GM 38.78% / 45.87%) |
| AQI: 0.98 (AQ_t 0.59 / AQ_t-1 0.60) |
| SGI: 0.99 (Revenue 3.20b / 3.24b) |
| TATA: -0.06 (NI 235.6m - CFO 695.4m) / TA 8.35b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of ENTG shares?
Over the past week, the price has changed by +22.58%, over one month by +35.41%, over three months by +64.80% and over the past year by +30.87%.
Is ENTG a buy, sell or hold?
- StrongBuy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ENTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 129.2 | -6.2% |
| Analysts Target Price | 129.2 | -6.2% |
| ValueRay Target Price | 150.8 | 9.5% |
ENTG Fundamental Data Overview February 12, 2026
P/E Forward = 41.1523
P/S = 6.3284
P/B = 5.117
P/EG = 2.2629
Revenue TTM = 3.20b USD
EBIT TTM = 446.5m USD
EBITDA TTM = 836.2m USD
Long Term Debt = 3.84b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 3.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.44b USD (from netDebt column, last quarter)
Enterprise Value = 23.76b USD (20.23b + Debt 3.89b - CCE 360.4m)
Interest Coverage Ratio = 2.33 (Ebit TTM 446.5m / Interest Expense TTM 191.9m)
EV/FCF = 41.64x (Enterprise Value 23.76b / FCF TTM 570.7m)
FCF Yield = 2.40% (FCF TTM 570.7m / Enterprise Value 23.76b)
FCF Margin = 17.85% (FCF TTM 570.7m / Revenue TTM 3.20b)
Net Margin = 7.37% (Net Income TTM 235.6m / Revenue TTM 3.20b)
Gross Margin = 38.78% ((Revenue TTM 3.20b - Cost of Revenue TTM 1.96b) / Revenue TTM)
Gross Margin QoQ = 21.91% (prev 43.53%)
Tobins Q-Ratio = 2.85 (Enterprise Value 23.76b / Total Assets 8.35b)
Interest Expense / Debt = 1.15% (Interest Expense 44.9m / Debt 3.89b)
Taxrate = 10.02% (5.50m / 54.9m)
NOPAT = 401.8m (EBIT 446.5m * (1 - 10.02%))
Current Ratio = 3.35 (Total Current Assets 1.64b / Total Current Liabilities 488.6m)
Debt / Equity = 0.96 (Debt 3.89b / totalStockholderEquity, last quarter 4.07b)
Debt / EBITDA = 4.11 (Net Debt 3.44b / EBITDA 836.2m)
Debt / FCF = 6.02 (Net Debt 3.44b / FCF TTM 570.7m)
Total Stockholder Equity = 3.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.81% (Net Income 235.6m / Total Assets 8.35b)
RoE = 6.07% (Net Income TTM 235.6m / Total Stockholder Equity 3.88b)
RoCE = 5.78% (EBIT 446.5m / Capital Employed (Equity 3.88b + L.T.Debt 3.84b))
RoIC = 5.18% (NOPAT 401.8m / Invested Capital 7.75b)
WACC = 12.45% (E(20.23b)/V(24.12b) * Re(14.65%) + D(3.89b)/V(24.12b) * Rd(1.15%) * (1-Tc(0.10)))
Discount Rate = 14.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF Debug] Terminal Value 63.73% ; FCFF base≈468.9m ; Y1≈472.7m ; Y5≈508.6m
Fair Price DCF = 8.87 (EV 4.78b - Net Debt 3.44b = Equity 1.35b / Shares 151.6m; r=12.45% [WACC]; 5y FCF grow 0.40% → 2.90% )
EPS Correlation: -56.58 | EPS CAGR: -10.47% | SUE: 0.86 | # QB: 1
Revenue Correlation: -0.32 | Revenue CAGR: 6.54% | SUE: 0.55 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.70 | Chg30d=+0.064 | Revisions Net=-2 | Analysts=9
EPS current Year (2026-12-31): EPS=3.31 | Chg30d=+0.096 | Revisions Net=+2 | Growth EPS=+20.3% | Growth Revenue=+6.6%
EPS next Year (2027-12-31): EPS=4.28 | Chg30d=+0.368 | Revisions Net=+0 | Growth EPS=+29.4% | Growth Revenue=+8.8%